Latest Orexo News & Updates

See the latest news and media coverage for Orexo. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Orexo

Pharmaceutical company with drug delivery technology platform

orexo.se
Headquarters
Fyrislund, Sweden
Founded year
1995
Company type
Public company
Number of employees
80–200
Industry
Pharmaceuticals

Last updated

Latest news about Orexo

In short: Orexo reported widened losses in Q2 2026 following the divestment of its Zubsolv US rights and a subsequent organizational restructuring.

Company announcements

Orexo

Orexo reports Q2 2026 interim results

Total net revenues were SEK 3.5 million with a net loss of SEK 102.5 million, while advancing pipeline programs including Izipry and OX640.

Orexo

Orexo calls for early bond redemption

It notifies holders of the senior secured social bonds 2024/2028 of the planned early redemption and provides investor relations contact details.

Orexo

Orexo designs rescue medication for adulterated opioids

The OX390 program is developed with BARDA to combat overdose from adulterated opioids.

Unlock all announcements with a

Media coverage

Dagens industri

Ökade förluster för Orexo

The specialty pharmaceutical company Orexo reports a post-tax result of minus 103 million kronor for the second quarter of 2026 (minus 97.5). The result...

Yahoo Finance

Orexo announces positive outcome from an in-vivo study of OX390

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces positive data from a pre-clinical in-vivo study on the nasal absorption of atipamezole when delivered with...

Unlock all articles with a

Never miss news about Orexo

Track Orexo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.